STAG2 and Ewing sarcoma: Whether STAG2 is prognostic among patients with localised Ewing sarcoma treated with standard of care vincristine/doxorubicin/cyclophosphamide alternating with ifosfamide/etoposide (VDC/IE) remains a central question in future efforts to test-risk-stratified therapy in this population.